Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32305075.
- Also identified by DOI 10.1016/S2468-1253(20)30119-9 and PMC identifier 7162648.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic is changing the management of many chronic diseases, including that of patients with inflammatory bowel diseases (IBD). In particular, the performance of routine endoscopy is temporarily suspended, and only emergency endoscopy is allowed in many countries where severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread. We highlight different scenarios in which endoscopy should still be performed urgently in patients with IBD, as well as recommendations regarding the use of personal protective equipment. We suggest a pathway for performing safe endoscopy and discuss the potential risks of postponing endoscopy in IBD. Finally, we propose a post-pandemic plan for access to endoscopy.
Medical subject headings
- Coronavirus Infections
- Endoscopy, Digestive System
- Inflammatory Bowel Diseases
- Pneumonia, Viral